You are here

glofitamab

FDA grants priority reviews for Pfizer's Prevnar 20 for kids and Roche lymphoma candidate

Endpoints

Sun, 01/8/23 - 09:59 pm

priority review

bispecific antibodies

Roche takes over development of Biogen-partnered lymphoma drug

BioPharma Dive

Tue, 12/20/22 - 11:11 am

ASH: Roche touts Lunsumio's durable efficacy as AbbVie, Regeneron plot lymphoma bispecific battle

Fierce Pharma

Mon, 12/12/22 - 10:21 am

Roche trumpets new glofitamab data in lymphoma at ASCO

Pharmaforum

Fri, 05/27/22 - 10:24 am

bispecific antibodies